Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article | Monograph
Number of items: 21.


D'Oronzo, S., Coleman, R., Brown, J. et al. (1 more author) (2019) Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management. Journal of Bone Oncology, 15. 100205. ISSN 2212-1366

Abraham, J., Coleman, R., Elias, A. et al. (9 more authors) (2018) Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG). Breast Cancer Research and Treatment, 171 (1). pp. 11-20. ISSN 0167-6806

Brown, J., Rathbone, E., Hinsley, S. et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. JNCI: Journal of the National Cancer Institute. djx280. ISSN 0027-8874

Handforth, C., D'Oronzo, S., Coleman, R. et al. (1 more author) (2018) Cancer Treatment and Bone Health. Calcified Tissue International, 102 (2). pp. 251-264.

Abraham, J., Caldera, H., Coleman, R. et al. (11 more authors) (2018) Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG). Breast Cancer Research and Treatment, 169 (1). pp. 1-7. ISSN 0167-6806

D'Oronzo, S., Brown, J. and Coleman, R. (2017) The role of biomarkers in the management of bone-homing malignancies. Journal of Bone Oncology, 9. pp. 1-9. ISSN 2212-1366

Squires, H., Pandor, A., Thokala, P et al. (5 more authors) (2017) Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. ISSN 1170-7690

Coleman, R. (2016) Bone targeted treatments in cancer – The story so far. Journal of Bone Oncology, 5 (3). pp. 90-92. ISSN 2212-1374

Baird, R., Banks, I., Cameron, D. et al. (53 more authors) (2016) An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. p. 608.

Pavlovic, M., Arnal-Estape, A., Rojo, F. et al. (16 more authors) (2015) Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis. JNCI: Journal of the National Cancer Institute, 107 (12). ARTN djv256. ISSN 0027-8874

Coleman, R., Aksnes, A-K., Naume, B. et al. (6 more authors) (2014) A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease. Breast Cancer Research and Treatment , 145 (2). pp. 411-418. ISSN 0167-6806

Hadji, P., Coleman, R., Gnant, M. et al. (1 more author) (2012) The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis. Annals of Oncology, 23 (11). pp. 2782-2790. ISSN 0923-7534

Coleman, R. and Hadji, P. (2012) Bone Oncology-An emerging multi-disciplinary specialty. Journal of Bone Oncology, 1 (1). p. 1. ISSN 2212-1366

Ring, A., Reed, M., Leonard, R. et al. (6 more authors) (2011) The treatment of early breast cancer in women over the age of 70. British Journal of Cancer, 105 (2). pp. 189-193. ISSN 0007-0920

Coleman, R., Woodward, E., Brown, J. et al. (11 more authors) (2011) Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast Cancer Research and Treatment, 127 (2). pp. 429-438. ISSN 0167-6806

Coleman, R. and MacCallum, P. (2010) Treatment and secondary prevention of venous thromboembolism in cancer. British Journal of Cancer, 102. S17-S23. ISSN 0007-0920

Saxton, J.M., Daley, A., Woodroofe, N. et al. (5 more authors) (2006) Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment. BMC Cancer, 6 (35). ISSN 1471-2407

Vasey, P.A., Atkinson, R., Osborne, R. et al. (8 more authors) (2006) SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel gemcitabine as first-line chemotherapy for ovarian cancer. British Journal of Cancer, 94 (1). pp. 62-68. ISSN 0007-0920

Lester, J. and Coleman, R. (2005) Bone loss and the aromatase inhibitors. British Journal of Cancer, 93. S16-S22. ISSN 0007-0920

Serin, D., Verrill, M., Jones, A. et al. (6 more authors) (2005) Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study. British Journal of Cancer, 92 (11). pp. 1989-1996. ISSN 0007-0920


Beard, S.M., Coleman, R., Radford, J. et al. (1 more author) (1997) The use of Cisplatin and Paclitaxel as a first line treatment in ovarian cancer. Other. Guidance Notes for Purchasers (97/05). Trent Institute for Health Services Research, Universities of Leicester, Nottingham and Sheffield , Sheffield. ISSN 1900733129

This list was generated on Sun Jan 19 20:37:53 2020 GMT.